Free Trial

Genus (LON:GNS) Stock Price Crosses Above 200-Day Moving Average - Here's What Happened

Genus logo with Medical background

Genus plc (LON:GNS - Get Free Report)'s share price passed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of GBX 1,841.10 ($25.02) and traded as high as GBX 2,150 ($29.22). Genus shares last traded at GBX 2,130.17 ($28.95), with a volume of 60,056 shares.

Analysts Set New Price Targets

Separately, Shore Capital restated a "buy" rating on shares of Genus in a research report on Wednesday, April 30th.

Read Our Latest Stock Report on GNS

Genus Stock Down 0.7%

The firm has a market cap of £1.43 billion, a PE ratio of 181.42, a P/E/G ratio of 2.87 and a beta of 0.37. The company has a debt-to-equity ratio of 53.12, a quick ratio of 1.08 and a current ratio of 1.80. The firm's 50-day moving average price is GBX 2,028.92 and its two-hundred day moving average price is GBX 1,843.64.

Genus Company Profile

(Get Free Report)

Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells breeding pigs and semen to breed pigs with various characteristics for pork production under the PIC brand.

Featured Stories

Should You Invest $1,000 in Genus Right Now?

Before you consider Genus, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genus wasn't on the list.

While Genus currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Don’t Miss These Top 3 Defense Stocks Set To Gain
Triple-Digit Gains: These 4 Nuclear Stocks Have Even More Upside Ahead
3 Made in America Stocks Under $20 You Need to See!

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines